K
Keiko Shiratori
Researcher at Mitsubishi Tanabe Pharma
Publications - 170
Citations - 6651
Keiko Shiratori is an academic researcher from Mitsubishi Tanabe Pharma. The author has contributed to research in topics: Autoimmune pancreatitis & Pancreatitis. The author has an hindex of 36, co-authored 167 publications receiving 6134 citations.
Papers
More filters
Journal ArticleDOI
Secretin as a potential mediator of antiulcer actions of mucosal protective agents.
Tadashi Takeuchi,Keiko Shiratori,Shin-ichiro Watanabe,Jenq-Her Chang,Yuriko Moriyoshi,Kyoko Shimizu +5 more
TL;DR: It is concluded that theAntiulcer effect of these drugs could in part be attributable to their unique ability to release endogeneous secretin, and that secretin is a potential mediator of the antiulcer actions of mucosal protective agents.
Journal ArticleDOI
Investigation of ornithine carbamoyltransferase as a biomarker of liver cirrhosis.
Noriko Matsushita,Etsuko Hashimoto,Katsutoshi Tokushige,Kazuhisa Kodama,Maki Tobari,Tomomi Kogiso,Nobuyuki Torii,Makiko Taniai,Keiko Shiratori,Hiroshi Murayama +9 more
TL;DR: The OCT level is a useful surrogate marker of cirrhosis, particularly in PSC patients, and the role of OCT should be further evaluated in order to improve the understanding of the pathogenesis of these diseases.
Journal ArticleDOI
Plaunotol inhibits postprandial gastrin release by its unique secretin-releasing action in humans.
TL;DR: It is indicated that plaunotol inhibits postprandial gastrin release by its unique secretin-releasing action.
Journal ArticleDOI
A novel IgM class autoantibody to a hepatocyte-related 190 kDa molecule in patients with type 1 autoimmune hepatitis
Katsumi Yamauchi,Naoko Yamaguchi,Takaji Furukawa,Kazuko Takatsu,Toshimi Nakanishi,Mina Sasaki,Etsuko Isono,Katsutoshi Tokushige,Tatsuji Komatsu,Keiko Shiratori +9 more
TL;DR: It is hypothesized that a hepatocyte‐specific monoclonal antibody from Epstein‐Barr virus‐transformed peripheral blood mononuclear cells obtained from a patient with autoimmune hepatitis may play a role in the immunopathogenesis of AIH.
Journal Article
[Fecal elastase-1 test: clinical evaluation of a new noninvasive pancreatic function test].
TL;DR: Fecal elastase-1 may be recommended as a new, noninvasive tubeless test of pancreatic function and significant correlation was observed between FE-1 and secretory data including juice volume, maximum HCO3- concentration, and amylase output obtained form secretin test.